AstraZeneca PLC Capital Reinvestment Ratio
AstraZeneca PLC capital reinvestment ratio. AstraZeneca PLC (AZNN) has a Capital Reinvestment Ratio of 0.55x as of December 2025, meaning it reinvests 1% of its operating cash flow (MX$2.34 Billion) in capital expenditures (MX$1.29 Billion). See AZNN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AstraZeneca PLC (2014–2025)
Capital reinvestment ratio of AstraZeneca PLC from 2014 to 2025. This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 12 annual periods. See AZNN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
AstraZeneca PLC Capital Reinvestment Ratio by Year (2014–2025)
AstraZeneca PLC capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see AstraZeneca PLC cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | MX$14.57 Billion | MX$5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | MX$11.86 Billion | MX$4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | MX$10.36 Billion | MX$3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | MX$9.81 Billion | MX$1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | MX$5.96 Billion | MX$1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | MX$4.80 Billion | MX$961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | MX$2.97 Billion | MX$979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | MX$2.62 Billion | MX$1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | MX$3.58 Billion | MX$1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | MX$4.14 Billion | MX$2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | MX$3.32 Billion | MX$1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | MX$7.06 Billion | MX$1.01 Billion | — |